Insider Trading activities of Medimmune Inc /de insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Medimmune Inc /de since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Medimmune Inc /de since year 2005. Table 2 shows the detailed insider transactions of Medimmune Inc /de since 2005. The reporting company's ticker symbol is MEDI. The reporting company's CIK number is 873591.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $6,085,361.
The total value of stock option exercises since 2005 is $4,571,265.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Medimmune Inc /de (MEDI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2007-03 0 $0 0 $0 286,482 $2,119,966
2007-02 0 $0 76,463 $2,374,276 75,000 $184,350
2006-12 0 $0 0 $0 109,326 $268,723
2006-05 0 $0 0 $0 30,000 $84,990
2006-03 0 $0 0 $0 16,140 $44,385
2006-02 0 $0 112,202 $3,711,085 136,202 $1,868,851

Table 2. Detailed insider stock purchases, sales, and option exercises of Medimmune Inc /de insiders (MEDI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-03-23 Mott David M (Vice Chairman, CEO & President) Option Ex 129,389 7.40 957,478
2007-03-21 Mott David M (Vice Chairman, CEO & President) Option Ex 53,593 7.40 396,588
2007-03-19 Mott David M (Vice Chairman, CEO & President) Option Ex 103,500 7.40 765,900
2007-02-13 Zoth Lota S (Senior Vice President & CFO) Sale 1,463 31.38 45,901
2007-02-08 Connor Edward M (Executive Vice President, CMO) Sale 75,000 31.04 2,328,375
2007-02-08 Connor Edward M (Executive Vice President, CMO) Option Ex 75,000 2.46 184,350
2006-12-06 Mott David M (Vice Chairman, CEO & President) Option Ex 109,326 2.46 268,723
2006-05-01 Macklin Gordon S (Director) Option Ex 30,000 2.83 84,990
2006-03-08 Mott David M (Vice Chairman, CEO & President) Option Ex 16,140 2.75 44,385
2006-02-15 Connor Edward M (EVP, Clinical Dev., CMO) Option Ex 24,000 2.75 66,000
2006-02-08 Kiener Peter A (SVP, Research) Sale 12,000 33.41 400,955
2006-02-08 Kiener Peter A (SVP, Research) Option Ex 12,000 23.45 281,400
2006-02-07 Hackman Franklin Barbara (Director) Sale 40,000 33.68 1,347,040
2006-02-07 Hackman Franklin Barbara (Director) Option Ex 40,000 6.75 270,000
2006-02-03 Mathers Edward T (SVP, Corporate Dev.) Sale 40,000 32.59 1,303,440
2006-02-03 Mathers Edward T (SVP, Corporate Dev.) Option Ex 40,000 23.81 952,400
2006-02-03 Anido Armando (EVP, Sales and Mktg) Sale 11,562 32.68 377,788
2006-02-03 Anido Armando (EVP, Sales and Mktg) Option Ex 11,562 23.81 275,291
2006-02-03 Young James F (President, R&D) Sale 8,640 32.62 281,862
2006-02-03 Young James F (President, R&D) Option Ex 8,640 2.75 23,760

Insider trading activities including stock purchases, stock sales, and option exercises of MEDI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Medimmune Inc /de (symbol MEDI, CIK number 873591) see the Securities and Exchange Commission (SEC) website.